CG Oncology (CGON) Operating Leases (2023 - 2026)
CG Oncology (CGON) posted Operating Leases of $3.5 million for Q1 2026, up 12.97% on a QoQ basis from $3.1 million in Q4 2025, and up 349.3% year-over-year from $781000.0 in Q1 2025.
CG Oncology (CGON) Operating Leases (2023 - 2026) Analysis & Trends
CG Oncology's Operating Leases history runs 4 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- Quarterly Operating Leases rose 349.3% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 349.3% YoY) and the FY2025 annual result came in at $3.1 million, up 5873.08% from the prior year.
- Operating Leases was $3.5 million for Q1 2026 at CG Oncology, up from $3.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $3.5 million in Q1 2026 and bottomed at $52000.0 in Q4 2024.
- A 4-year average of $1.2 million and a median of $475000.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases sank 78.69% — and 2025, when it soared 5873.08%.
- CG Oncology's Operating Leases stood at $244000.0 in 2023, then sank by 78.69% to $52000.0 in 2024, then surged by 5873.08% to $3.1 million in 2025, then rose by 12.97% to $3.5 million in 2026.
- Business Quant data shows CGON's Operating Leases at $3.5 million in Q1 2026, $3.1 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.51 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 3.33 Mn |
| Jun 30, 2025 | 706,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 184,000.00 |
| Dec 31, 2023 | 244,000.00 |